Proteasome mediated degradation of CDC25C and Cyclin B1 in Demethoxycurcumin treated human glioma U87 MG cells to trigger G2/M cell cycle arrest
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 356, 76-89
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology (Purse Grant I–No. Fin.III (i)/155/DU-DST PURSE, Purse Grant II-No. RC/2016/944-II DST PURSE)
- Council of Scientific & Industrial Research (09/045(1028)/2010-EMR-1)
- Department of Science and Technology (DST-Grant No. Fin.III (i)/155/DU-DST PURSE)
- UGC (41-359/2012-SR)
This publication has 41 references indexed in Scilit:
- Targeting the ubiquitin–proteasome system for cancer therapyExpert Opinion on Therapeutic Targets, 2013
- Mitochondrial superoxide mediates doxorubicin-induced keratinocyte apoptosis through oxidative modification of ERK and Bcl-2 ubiquitinationBiochemical Pharmacology, 2012
- The ubiquitin-proteasome system in glioma cell cycle controlCell Division, 2012
- Demethoxycurcumin Retards Cell Growth and Induces Apoptosis in Human Brain Malignant Glioma GBM 8401 CellsEvidence-Based Complementary and Alternative Medicine, 2012
- Demethoxycurcumin induces Bcl-2 mediated G2/M arrest and apoptosis in human glioma U87 cellsBiochemical and Biophysical Research Communications, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Response of small intestinal epithelial cells to acute disruption of cell division through CDC25 deletionProceedings of the National Academy of Sciences, 2009
- Redox Regulation of Cell SurvivalAntioxidants & Redox Signaling, 2008
- Role of Reactive Oxygen Intermediates in Cellular Responses to Dietary Cancer Chemopreventive AgentsPlanta Medica, 2008
- Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topologyNature Cell Biology, 2006